EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms

Elif Nilay Kaya, Ali Aşcı

Pharmata · 13.11.2026 · 6 (3) · 112-121

DOI: 10.62425/pharmata.2021205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmata, online erschienen am 13.11.2026. Verfasst von Elif Nilay Kaya und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Not applicable.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to develop and validate simple, sensitive, and cost-effective UV-Visible and first-derivative spectrophotometric methods for the quantitative determination of chlorpromazine in pharmaceutical dosage forms.

Methods

The UV-Visible spectrophotometric method was performed at 254 nm, whereas the first-derivative spectrophotometric method was evaluated at wavelengths of 247 nm and 261 nm. Both methods were comprehensively validated according to ICH Q2(R1) guidelines with respect to linearity, accuracy, precision, limit of detection and limit of quantification.

Results

Linearity was achieved over the concentration range of 1-25 μg/mL for all proposed procedures. The developed methods demonstrated satisfactory accuracy, with relative error values ranging from -1.87% to 6.64%, and acceptable precision, with relative standard deviation values ranging from 0.04% to 8.64% across intra-day and inter-day evaluations. The limits of detection (LOD) and quantification (LOQ) were calculated as 0.29 μg/mL and 0.89 μg/mL, respectively. The first-derivative spectrophotometric approach provided improved spectral resolution and reduced the influence of potential spectral overlap from formulation components. The validated methods were successfully applied to the determination of chlorpromazine in tablet and ampoule pharmaceutical preparations.

Conclusion

The obtained results indicate that the proposed spectrophotometric methods provide rapid, reliable and economical alternatives for routine pharmaceutical quality

Förderung

  • Not applicable

Zitieren

APA

Kaya, E. N., & Aşcı, A. (2026). Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms. Pharmata, 6(3), 112-121. https://doi.org/10.62425/pharmata.2021205

Vancouver

Kaya EN, Aşcı A. Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms. Pharmata. 2026;6(3):112-121. doi:10.62425/pharmata.2021205

BibTeX
@article{Kaya2026,
  author = {Kaya, Elif Nilay and Aşcı, Ali},
  title = {Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms},
  journal = {Pharmata},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {112--121},
  doi = {10.62425/pharmata.2021205}
}
Kostenlos starten →